Rena Hirani Awarded the Inaugural James Isbister Prize at the Blood ISBT 2025
Rena Hirani, Senior Research Fellow at the Australian Red Cross Lifeblood, shared on LinkedIn:
”Following a big week of wins, I am thrilled to share yet more exciting news.
I was awarded the inaugural James Isbister Prize at the recent Blood ISBT 2025 Conference in Perth.
This honour marks a significant milestone in my research career, and I’m deeply grateful for the recognition.
Professor James Isbister is a pioneering figure in haematology, transfusion medicine and medical education.
His work shaped global standards in patient blood management.
Prof. Isbister completed his postgraduate training in internal medicine at St Vincent’s Hospital.
He was part of a team that performed the first successful Australian allogeneic bone marrow transplants, which is now commonly used to treat blood cancers.
Transfusion medicine became his passion since every speciality involves blood.
This prize, named after him in honour of his achievements to Australian medicine, was awarded for significant contributions in research into blood and blood products, education of the medical community and encouragement of appropriate clinical use of blood and plasma products for better healthcare.
The occasion was made even more memorable by the fact that James, energetically in his 80s, was present to award me personally which was a deeply meaningful honour.
I would also like to recognise the long term support of my work by Australian Red Cross Lifeblood, ANZSBT and National Blood Authority, Australia.
It is a true privilege to be a part of the transfusion community.”
More winner stories featured in Hemostasis Today.
-
Nov 2, 2025, 14:172019 ESC/EAS Guidelines for the Management of Dyslipidaemias Discussion with Lale Tokgözoğlu and Jeanine Roeters van Lennep
-
Nov 2, 2025, 14:14Nihar Desai: Post-Transplant Dysphagia
-
Nov 2, 2025, 14:13Zia Choudhry Launchs a New Digital Education Platform Designed to Inform and Empower People Living With wAIHA
-
Nov 2, 2025, 14:13Rahul Bhargava: Landmark Study Shows Excellent Outcomes in Pediatric AML Transplant
-
Nov 2, 2025, 10:17ESO: Register for the Live WSC 2025 Highlights Webinar
-
Nov 2, 2025, 14:21Claude Franceschi: I Advise You to Understand the Hemodynamic Pathophysiology of Venous Diseases Rather than Blindly Applying Ablation Techniques or Venous Stent Placement
-
Nov 2, 2025, 14:15Krishna Aragam: Why are (DCM) and Heart Failure About Twice as Common in Individuals of Self-Identified Black Race?
-
Nov 2, 2025, 14:15Raul Santos: Waist-to-Height Ratio and Coronary Artery Calcium Incidence
-
Nov 2, 2025, 14:12Steven AR Murphy: Urolithin A Shows Immune Rejuvenation and Mitochondrial Benefits in New Trial
-
Nov 2, 2025, 10:31Cihan Ay and RIETE Investigators Team Present External Validation of the VTE-PREDICT Score
-
Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Oct 28, 2025, 06:49Lukas Gaats: Researchers Are Building Reproductive Organoids
-
Nov 2, 2025, 14:17Anamaria B: Your Mother Still Runs Part of Your DNA
-
Nov 2, 2025, 10:57Paul Bolaji on Launching The First Centralised Nigerian National Stroke Registry
-
Nov 2, 2025, 10:03Mark Stoffels: A Stroke Can Change Lives in an Instant, But With Timely Expert Care Recovery is Possible
-
Nov 2, 2025, 09:43Louise Bannon Celebrates Barbara Adams Krolak’s 10-Year Anniversary at ISTH
-
Nov 2, 2025, 08:06Sanam Loghavi Recognized at Inaugural Women in Hematology U.S. Focus Meeting 2025